Innovation: How BIG BioPharma is Getting it Done March 10, 2011

Everyone is talking about innovation. The innovation gap, the importance of innovation, can big companies be innovative, is Silicon Valley still the home of innovation? This panel discussion will feature representatives from BIG BioPharma who will share their efforts to stay on top of the innovation game and how you can participate. Featured initiatives will include grants, venture arms, incubators, funding early stage research, interfacing with VCs and much more. Our Panel discussions are candid, interactive and informal. We want you to walk away with the real story behind how things work so you can make it happen yourself. This Panel will be followed by a Networking Reception.

Speaker

Christopher Haskell, PhD, Head, US Science Hub, Bayer HealthCare Pharmaceuticals

Sylvaine Cases, Ph.D. Sanofi-Aventis US, External Innovation

Yael Weiss, PhD, Director, Licensing & External Research, Merck Research Laboratories

Thomas F. Zioncheck, Ph.D, Senior Director, Business Development, Genentech

Lead Facilitator: Scott M. Iyama, Corporate Senior Associate, Orrick, Herrington & Sutcliffe LLP

Official Website: http://innovationbigbiopharma.eventbrite.com/